COR vs. IDXX: Cencora vs. IDEXX Laboratories Stock Comparison

Company Profile

Cencora (COR) and IDEXX Laboratories (IDXX) both fall under the Health Care Equipment & Services industry group, but COR is classified in Health Care Providers & Services while IDXX is classified in Health Care Equipment & Supplies.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Cencora (COR) is defensive at 0.56 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Cencora (COR) at 129.01% and IDEXX Laboratories (IDXX) at 68.93% turn shareholders’ equity into profit at rates above their industry benchmark ranges for ROE. That is a strong capital-efficiency signal, though leverage and the equity base still matter.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Cencora (COR) at 1.03%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Cencora (COR) at 1.27%, which runs around its industry’s norm.

Profitability Metrics

Growth

Only one side can be read here: IDEXX Laboratories (IDXX) reports revenue growth of 10.42%, ranked against its industry; Cencora (COR) has no revenue growth figure this period.

Cencora (COR) at 125.50% clears its industry range for EPS growth, a much stronger earnings trajectory than IDEXX Laboratories (IDXX) at 22.59%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Both Cencora (COR) at 0.94 and IDEXX Laboratories (IDXX) at 1.19 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

IDEXX Laboratories (IDXX) at 0.52 is near its industry mid-range for debt-to-equity ratio, while Cencora (COR) at 3.06 sits above its benchmark range, pointing to a heavier debt load relative to equity.

Financial Strength Metrics

Dividends

IDEXX Laboratories (IDXX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a yield of 0.71%, ranking against industry peers normally.

IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Cencora (COR) reports a payout of 17.45%, ranking against industry peers normally.

Dividend Metrics

Valuation

Cencora (COR) at 18.58 sits in the cheaper P/E ratio quartile, while IDEXX Laboratories (IDXX) at 45.56 is closer to its industry’s usual earnings multiple — a discount for COR, though growth and earnings durability still matter.

Cencora (COR) at 0.19 sits in the cheaper P/S ratio quartile while IDEXX Laboratories (IDXX) at 11.42 prices above its industry range — a wide gap in sales valuation between them.

Measured against book value, both Cencora (COR) at 17.29 and IDEXX Laboratories (IDXX) at 28.50 look expensive — each P/B ratio sits above its industry’s benchmark range.

Valuation Metrics